Lion Street Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-531
Closed -$414K 305
2025
Q2
$414K Buy
531
+21
+4% +$16.3K 0.13% 172
2025
Q1
$421K Buy
510
+56
+12% +$46.6K 0.13% 166
2024
Q4
$351K Buy
454
+6
+1% +$4.97K 0.11% 182
2024
Q3
$397K Buy
448
+10
+2% +$8.99K 0.14% 165
2024
Q2
$396K Sell
438
-8
-2% -$6.4K 0.15% 148
2024
Q1
$260K Hold
446
0.11% 201
2023
Q4
$260K Sell
446
-5
-1% -$2.92K 0.11% 201
2023
Q3
$243K Buy
+451
New +$232K 0.08% 212
2020
Q2
Sell
-92
Closed -$13K 236
2020
Q1
$13K Buy
+92
New +$12.6K 0.07% 134

Other funds holding LLY

Lion Street Advisors's LLY Position: Q3 2025 in Review

Lion Street Advisors sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 531 shares — an estimated $414K sold.

Lion Street Advisors first reported a position in LLY in Q1 2020 and held it in 9 quarters. The position peaked at $421K in Q1 2025. 3,903 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Lion Street Advisors reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Lion Street Advisors sold 531 Eli Lilly shares in Q3 2025, an estimated $414K.
  • Lion Street Advisors first reported a position in Eli Lilly in Q1 2020 and held it in 9 quarters.
  • Lion Street Advisors's Eli Lilly position peaked at $421K in Q1 2025.
  • 3,903 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Lion Street Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.